Since 2022, Mpox cases have increased across the continent, with deeply concerning statistics as of July 2024 due to the emergence of a more virulent strain. The World Health Organization (WHO) has declared the outbreak a Public Health Emergency of International Concern (PHEIC), and the Africa Centers for Disease Prevention (Africa CDC) has reported a total of 37,583 cases and 1,451 deaths across 15 African countries.
Amref public health experts, Boniface Hlabano (Program Manager, Global Health Security Unit) and Mary Mathenge (Directorate of Populations Health and Environment, Amref Kenya), explore the current state of the Mpox crisis, the challenges it poses, and how Amref is working to raise awareness and curb the outbreak's spread.
Follow us:
Twitter: twitter.com/AMREFUSA
Facebook: facebook.com/amrefusa
Instagram: instagram.com/amrefusa/
LinkedIn: linkedin.com/company/amref-usa
Visit our website: amrefusa.org/
Sign up for our Monthly eNewsletter: bit.ly/AmrefYTeNews
Donate: bit.ly/AmrefYTDonations
Or join Pamoja, our monthly giving community: bit.ly/AmrefYTPamoja.
2022 Annual Report: amrefusa.org/media-and-resources/annual-reports/
About Amref Health Africa in the USA:
The Amref Health Africa in the USA office raises awareness and critically needed funds for our work in Africa. In 2021, 92% of our funds raised went directly toward programming. Amref Health Africa in the USA is registered with the U.S. Internal Revenue Service as a 501 (C)(3) organization, and contributions to Amref Health Africa in the USA are tax-deductible to the maximum extent permitted under the law. EIN 13-1867411
- Understanding Mpox: Challenges, Solutions, & Amref’s Response ( Download)
- National AMR action plans and immunization programmes ( Download)
- UNLEASHING the KRAKEN Special: A Monkeypox Deep-Dive Analysis ( Download)
